Reduced antioxidant defense systems in schizophrenia and bipolar I disorder

被引:90
|
作者
Raffa, Monia [2 ]
Barhoumi, Sana [2 ]
Atig, Fatma [2 ]
Fendri, Chiraz [1 ]
Kerkeni, Abdelhamid [2 ]
Mechri, Anwar [1 ,3 ]
机构
[1] Univ Monastir, Fac Med, Res Lab Vulnerabil Psychot Disorders, Monastir 5000, Tunisia
[2] Univ Monastir, Res Lab Trace Elements Free Rad & Antioxidants, Dept Biophys, Fac Med, Monastir 5000, Tunisia
[3] Univ Monastir, Univ Hosp Monastir, Dept Psychiat, Res Lab Vulnerabil Psychot Disorders,Fac Med, Monastir 5000, Tunisia
关键词
Antioxidant enzymes; Bipolar disorder; Glutathione; Oxidative stress; Schizophrenia; SERUM SUPEROXIDE-DISMUTASE; ACID REACTIVE SUBSTANCES; OXIDATIVE STRESS; LIPID-PEROXIDATION; GLUTATHIONE-PEROXIDASE; NITRIC-OXIDE; ENZYME-ACTIVITIES; DIFFERENT FORMS; CORTEX; MALONDIALDEHYDE;
D O I
10.1016/j.pnpbp.2012.07.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Numerous evidence and proofs suggest that the oxidative stress contributes to the pathogenesis of schizophrenia (SZ) and bipolar disorder (BD). The aim of this study is to determine the glutathione levels and the antioxidant enzyme activities in blood samples of patients suffering from SZ and patients with bipolar disorder in comparison with the healthy controlled subjects. It was a case-controlled study carried on upon three groups: forty-six SZ patients (41 men and 5 women, mean age = 33.2 +/- 7 years), thirty BD patients (25 men and 5 women, mean age = 31.3 +/- 8 years) and forty healthy controls (33 men and 7 women, mean age = 32.3 +/- 7 years). The glutathione levels are the total glutathione (GSHt), the reduced glutathione (GSHr), and the oxidized glutathione (GSSG) and the antioxidant enzyme activities that are the superoxide dismutase (SOD), the glutathione peroxidase (GPx), and the catalase (CAT) are determined by the spectrophotometer. We noticed that the GSHt and the GSHr levels significantly decreased in both SZ and BD patients in comparison with the healthy control subjects. As for SOD and CAT activities they remained lower for the patients with SZ when compared both with the controls or the BD patients. We noticed as well that the CAT activity was significantly lower in the BD group than that in the control group, whereas, GPx activity showed no significant change in each group. Hence, this report of the decreased plasma levels of GSHt and GSHr, and the impaired antioxidant enzyme activities in SZ and BD patients aims at highlighting the GSH deficit that seems to be contributing to these disorders, and showing that it may be an important indirect biomarker of the oxidative stress for the SZ and BD. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
  • [21] Comparing adaptive coding of reward in bipolar I disorder and schizophrenia
    Kaliuzhna, Mariia
    Kirschner, Matthias
    Tobler, Philippe N.
    Kaiser, Stefan
    HUMAN BRAIN MAPPING, 2023, 44 (02) : 523 - 534
  • [22] Chronotype distribution in bipolar I disorder and schizophrenia in a Korean sample
    Ahn, Yong Min
    Chang, Jaeseung
    Joo, Yeon Ho
    Kim, Seong Chan
    Lee, Kyu Young
    Kim, Yong Sik
    BIPOLAR DISORDERS, 2008, 10 (02) : 271 - 275
  • [23] Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder
    Digney, A
    Keriakous, D
    Scarr, E
    Thomas, E
    Dean, B
    BIOLOGICAL PSYCHIATRY, 2005, 57 (07) : 711 - 715
  • [24] Cognitive impairment in late life schizophrenia and bipolar I disorder
    Meesters, Paul D.
    Schouws, Sigfried
    Stek, Max
    de Haan, Lieuwe
    Smit, Jan
    Eikelenboom, Piet
    Beekman, Aartjan
    Comijs, Hannie
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2013, 28 (01) : 82 - 90
  • [25] Mapping Mitochondrial Complex I in Bipolar Disorder versus Schizophrenia
    Andreazza, Ana Cristina
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 121S - 122S
  • [26] A comparison of decision making in patients with bipolar i disorder and schizophrenia
    Martino, Diego J.
    Strejilevich, Sergio A.
    SCHIZOPHRENIA RESEARCH, 2014, 156 (01) : 135 - 136
  • [27] Multimodal Intervention Program in Bipolar I Disorder and Schizophrenia: Prisma
    Lopez, Carlos A. Jaramillo
    Bearden, Carrie E.
    Escobar, Javier I.
    Freimer, Nelson B.
    Kapczinski, Flavio
    Palacio, Juan David
    Palacio, Andres F.
    Saldarriaga, Santiago
    Escobar, Manuel I. Valencia
    Vargas, Cristian
    Ospina, Sigifredo
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 261S - 261S
  • [28] Hippocampal Volume Is Reduced in Schizophrenia and Schizoaffective Disorder But Not in Psychotic Bipolar I Disorder Demonstrated by Both Manual Tracing and Automated Parcellation (FreeSurfer)
    Arnold, Sara J. M.
    Ivleva, Elena I.
    Gopal, Tejas A.
    Reddy, Anil P.
    Jeon-Slaughter, Haekyung
    Sacco, Carolyn B.
    Francis, Alan N.
    Tandon, Neeraj
    Bidesi, Anup S.
    Witte, Bradley
    Poudyal, Gaurav
    Pearlson, Godfrey D.
    Sweeney, John A.
    Clementz, Brett A.
    Keshavan, Matcheri S.
    Tamminga, Carol A.
    SCHIZOPHRENIA BULLETIN, 2015, 41 (01) : 233 - 249
  • [29] The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder
    Torres, K. C. L.
    Souza, B. R.
    Miranda, D. M.
    Nicolato, R.
    Neves, F. S.
    Barros, A. G. A.
    Dutra, W. O.
    Gollob, K. J.
    Correa, H.
    Romano-Silva, M. A.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (02): : 214 - 219
  • [30] Neural stem cell proliferation is significantly reduced in schizophrenia, but not in depression or bipolar disorder
    Fritzen, S
    Strobel, A
    Schmitt, A
    Lesch, KP
    Reif, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S14 - S15